A nanoemulsion based gel loaded with the β-CD-MTX inclusion complex provides a hopeful approach to enhance topical MTX delivery, improves therapeutic efficacy, and reduces systemic side effects, thereby addressing important limitations of traditional RA therapy.
Methotrexate is an effective disease-modifying antirheumatic drug (DMARD) widely used in the management of rheumatoid arthritis and psoriasis; however, its conventional administration is associated with poor patient compliance and systemic adverse effects. The present study aimed to develop and optimize methotrexate-lo...
Shilpa Hanamant Jagtap, Dhyanendra Singh Baghel· International Journal of Dru...· 0 citations
Introduction/ Objective: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovial joints, leading to joint destruction and systemic complications. Existing therapies, such as Disease-Modifying Antirheumatic Drugs (DMARDs) and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs),...
Ashok Thulluru, C. Jangme, Vrushabh Patil· Recent Advances in Drug Deli...· 0 citations
Introduction Intra-articular corticosteroid injections (IACIs) provide an alternative treatment for inflammatory arthritis. Nevertheless, IACIs are limited by adverse effects, including injection-related pain, corticosteroid-induced chondrocyte toxicity, and progressive cartilage degeneration following prolonged use. M...
Shu-Jyuan Yang, Tzu-Hao Tseng, Po-Ju Ting et al.· International Journal of Nan...· 0 citations
Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by severe synovial inflammation, joint deformities, and progressive tissue destruction. Celastrol (Cel), a natural triterpenoid with anti-inflammatory and antioxidant activity, is a promising therapeutic candidate for RA; however, its a...
Ji-Quan Shen, Chang-Jian Zhou, Xing-Gao Wang et al.· Frontiers in Immunology· 2 citations· ⚡1
This review article offers a thorough examination of nanoemulgel-based drug delivery methods for rheumatoid arthritis (RA) treatment. The study delves into the fusion of nanotechnology with gel-based systems, underscoring their superior drug-delivery capabilities, controlled release, and targeted therapeutic potential...
Advanced nanomedicine represents a promising strategy for improving the safety, efficacy, and personalization of rheumatoid arthritis treatment and holds significant potential for transforming future clinical management of this debilitating autoimmune disease.
P. Swami, Ajita S. Kesharwani· Journal of Drug Delivery and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.